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Abstract The Philippines is a low middle-income, tropical
country in Southeast Asia. Infectious diseases remain the main
causes of morbidity, including tuberculosis. AIDS/HIV prev-
alence is still low at <1%, but is rapidly increasing. Fungal
disease surveillance has not been done, and its burden has
never been estimated. This becomes more important as the
population of immunocompromised patients increases, drawn
from patients with AIDS, TB, malignancies, and autoimmune
diseases requiring chronic steroid use. Using the methodology
of the LIFE program (www.LIFE-worldwide.org), estimates
were derived from data gathered from WHO, UNAIDS,
Philippine Health Statistics 2011, Philippine Dermatological
Society Health Information System database, HIV/AIDS and
ART registry of the Philippines, epidemiological studies such
as The TREAT Asia HIV Observational Database 2005, and
personal communication. Aspergillosis and candidiasis were
the top causes of fungal infections in the Philippines. Chronic
pulmonary aspergillosis (CPA), drawn from the number of
tuberculosis patients, affects 77,172 people. Allergic
bronchopulmonary aspergillosis (ABPA) and severe asthma
with fungal sensitization (SAFS) frequencies, which were de-
rived from the number of asthmatic patients, affect 121,113
and 159,869 respectively. Recurrent vulvovaginal candidiasis
(RVVC) affects 1,481,899 women. Other estimates
were cryptococcal meningitis 84, Pneumocystis pneumonia
391, oral candidiasis 3,467, esophageal candidiasis 1,522
(all in HIV-infected people), invasive aspergillosis (IA)
3,085, candidemia 1,968, candida peritonitis 246,
mucormycosis 20, fungal keratitis 358, tinea capitis 846 and
mycetoma 97 annually. A total of 1,852,137 (1.9% of popu-
lation) are afflicted with a serious fungal infection.
Epidemiological studies are needed to validate these esti-
mates, facilitating appropriate medical care of patients and
proper prioritization of limited resources.
Introduction
In the Philippines, most of the initial epidemiological studies
on mycoses focused on superficial fungal infections [1–3].
Since the 1950s, superficial mycoses have been in the top five
most common diagnoses in outpatient dermatology clinics [2].
For several decades, fungal diagnostic procedures in the
Philippines were not routinely done and were limited to the
isolation, culture, and identification of fungi involved in skin,
hair, and nail infections. Two university-based microbiology
departments conduct short courses in Diagnostic Mycology
on a regular basis. In the past, these used to cater solely for
dermatologists, because the course was a requirement in their
residency training. However, with the advent of AIDS and the
compromised patient, more infectious disease fellows and
medical laboratory personnel have enrolled in these courses.
The advent of AIDS, first described in the Philippines in
1984, led to a greater recognition of fatal fungal diseases [4].
Out of 470 HIV/AIDS patients seen in a tertiary general hos-
pital in the Philippines, 32.5% presented with opportunistic
infections [5]. Among the opportunistic infections, 32% were
due to Pneumocystis pneumonia, 4% to cryptococcal menin-
gitis, and 3% to oral thrush [5]. HIV cases are climbing steeply
in the Philippines (20–30% annual increase in the years 2013–
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2016), especially among men [4]. Patients who are on immu-
nosuppressive agents, or are immunocompromised due to
medical conditions and/or are critically ill, are also at an in-
creased risk of acquiring serious fungal infections, and such
patients are common in the urban centres of the Philippines.
There is no active surveillance done for serious fungal infec-
tions in the country, and epidemiological studies even for be-
nign superficial mycoses have been sparse. Although nation-
ally based surveillance programs are the gold-standard in es-
timating disease prevalence, they are usually costly and diffi-
cult to implement [6]. Therefore, the actuarial method used by
previous researchers was used in this study to estimate the
incidence and prevalence of serious fungal diseases, in which
results from previous epidemiological studies, populations at
risk, and epidemiological databases were used [6].
Methods
Applying the methodology of the LIFE program (www.LIFE-
worldwide.org), prevalence and incidence of serious fungal
infections were derived from data gathered from WHO,
UNAIDS, Philippine Health Statistics 2011, Philippine
Dermatological Society (PDS) Health Information System da-
tabase, HIV/AIDS and ART registry of the Philippines, epi-
demiological studies such as The TREAT Asia HIV
Observational Database 2005, and personal communication.
Results and discussion
Population and country profile
The Philippines is classified as lower middle income by the
World Bank. It is considered one of the promising newly in-
dustrialized countries, enjoying a steady economic growth at
the turn of the millennium, with a per capita 2013 gross do-
mestic product of $2,765. Based on the 2013 WHO statistical
profile, the population of the Philippines is 98,394,000, with
34% under the age of 15, and 6% over the age of 60. The
median age is 23. The number of hospital beds per population
was the lowest in Asia in 2010 [7]. Table 1 shows relevant
population statistics.
Burden of fungal infections
In 2016, a total of 1,852,137 severe fungal infections are esti-
mated to have occurred in the Philippines. Table 2 shows the
incidence and prevalence for selected serious fungal infec-
tions. Eighty percent of this is due to RVVC. However, local
practicing obstetricians think this number is too high, and
approximate that each general obstetrician sees 12–15 patients
with vulvovaginal candidiasis, three to four of whom have
RVVC per month. There are around 4,000 to 5,000 obstetri-
cians in the Philippines, so the maximum estimate for the
prevalence of RVVC would only be 240,000, ∼1.2 million
less than the estimate. Those with RVVC who consult a phy-
sician do not represent everyone in the population, and many
women suffer in silence. It is likely that many patients self-
medicate, since patients may purchase topical antifungals
without prescription or try local remedies. Clearly, this sub-
stantial issue needs addressing in the Philippines.
HIV/AIDS cases in the Philippines are few with a cumu-
lative number of cases at 34,999 since the first case was
reported in 1984. However, a sudden rise in cases has been
observed since 2009, with 83% of cumulative cases diag-
nosed between 2009 to present. Most of the newly diag-
nosed cases are in the 25–29 age group, and among men
who have sex with men [4, 8]. Our estimated incidences of
Pneumocystis pneumonia, cryptococcal meningitis, and oral
candidiasis were based on HIV/AIDS cases in the recent
past, which were relatively low but are increasing rapidly.
Adequate diagnosis of opportunistic fungal disease with the
highly sensitive and specific cryptococccal antigen lateral
flow device [9, 10] and Pneumocystis PCR are required
[11, 12]. It is not known if disseminated histoplasmosis con-
tributes to illness and death in AIDS in the Philippines, but
it is likely. Histoplasmin reactivity has been documented,
and at least nine cases of histoplasmosis have been reported
[2, 13, 14]. Hand in hand with an effective AIDS prevention
program and prompt and adequate treatment of cases with
antiretroviral drugs, proper management of opportunistic
fungal infections is required.
The Philippine prevalence of IA, CPA, ABPA, and
SAFS, diseases caused by Aspergillus sp., has never been
studied. However, several cases of pulmonary aspergillo-
sis have been documented. In 1975, a case of pulmonary
aspergillosis was reported in Manila in a 25-year-old male
who presented with a 7-year history of hemoptysis with-
out fever and anorexia, and who was diagnosed with tu-
berculosis but did not respond to anti-tuberculosis medi-
cines [15]. From February 1982 to May 1990, 16 cases of
pulmonary aspergillosis were seen at the Lung Center of





Below 15 years old 34.0 33,453,960
Above 40 years old 25.6 25,188,864
Above 60 years old 6.0 5,903,640
Females 15–50 years old 25.9 25,484,046
a (Epidemiology Bureau, Department of Health 2011)
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the Philippines [16]. Nine of them had inactive pulmonary
tuberculosis; 13 underwent lobectomy or segmentectomy
or cyst removal. From Jan 2000 to December 2002, 37
patients were diagnosed with aspergilloma, and all were
surgically managed. Ninety-two percent presented with
hemoptysis and 95% had tuberculosis [17]. In a retrospec-
tive study done in a private hospital in Manila, there
were 14 cases of aspergillosis seen from 1998-2004; five
were diabetics and three had renal transplants. Eleven
presented with pulmonary aspergillosis, and three had
extrapulmonary aspergillosis [18]. A case of primary la-
ryngeal aspergillosis in a 28-year-old who presented with
fever, cough, and cold a day after giving birth by caesar-
ean section was reported [19]. The Philippines is endemic
for TB, and urban and rural areas have high rates of
COPD [20]. TB and COPD are both associated with
CPA, and therefore it is probable that there are many
undiagnosed CPA cases, with some of them managed as
resistant TB cases. It is important to determine baseline
prevalence using available serological tests.
Candidemia among infants confined in the neonatal inten-
sive care unit was reported to affect 56 of 7,830 infants in
2004, and 31 of 7,830 infants in 2005 [21]. A case–control
study done in the same facility revealed that birthweight of
1,250 to 2,499 grams and gestational age of <28 weeks were
significantly associated with candidemia (p < 0.05) [21]. The
rate of candidemia in different countries varied from 1.2 to 25
per 100,000 population [22]. We have decided to use two per
100,000 population since exposure to risk factors for
candidemia may be low, and there are remarkably few hospi-
tals for this populous country [7]. In some developed coun-
tries, candidemia rates are increasing instead of decreasing
and may be due to increased survival of patients with severe
diseases or extremely low-birth weight, more aggressive in-
terventions in the form of surgery, transplants, invasive proce-
dures and devices, immunosuppressive therapy, and use of
broad-spectrum antibiotics [22]. These are resources that are
not accessible to most Filipinos.
In 1955, dermatologists surveyed the schools where two
children with tinea capitis studied; however, no additional
Table 2 Prevalence and incidence of selected serious fungal infections in the Philippines, 2016
Serious fungal iInfection Estimation method Totals Rate/100,000
Cryptococcal meningitis 7% of new AIDS diagnosis 84 Annual incidence 0.09
Pneumocystis pneumonia 31% of new AIDS diagnosis 391 Annual incidence 0.40
Invasive aspergillosis (IA) 10% of AML + an equal number in other
haematological conditions, 0.5% of
renal transplant patients, 4% of liver
transplant patients, and 1.3% of patients
hospitalized for COPD
3,085 Annual incidence 3
Chronic pulmonary aspergillosis (CPA) 22% of cavitary pulmonary TB, 2% of
non-cavitary pulmonary TB, annually,




2.5% of adult asthmatics 121,113 Prevalence 123
Severe asthma with fungal
sensitisation (SAFS)
33% of the most severe 10% of adult
asthmatics
159,869 Prevalence 162
Candidaemia 2/100,000 general population, 1.5 in
non-ICU and 0.5 in ICU
1,968 Annual incidence 2
Candida peritonitis 50% of incidence of candidemia in ICU 246 Annual incidence 0.25
Oral candidiasis 90% of HIV patients not on antiretrovirals
and CD4 < 200 × 106/L
3,467 Annual incidence 3.5
Oesophageal candidiasis 20% of HIV patients not on antiretrovirals and
CD4 < 200 × 106/l + 5% of HIV patients on
antiretrovirals
1,522 Annual incidence 1.5
Recurrent vulvovaginal candidiasis
(RVVC) (>4x/year)
5% of women 15–50 years of age 1,481,899 Prevalence 3,012
Mucormycosis 0.2 cases per 1,000,000 population 20 Annual incidence 0.02
Fungal keratitis Based on cases seen at a tertiary government
hospital in the NCR in 2015
358 Annual incidence 0.36
Tinea capitis Based on cases seen at Philippine Dermatological
Society training institutions in 2015
846 Annual incidence 0.86
Mycetoma Based on cases seen at Philippine
Dermatological Society training
institutions in 2015
97 Annual incidence 0.10
Total serious fungal infection burden 1,852,137
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case was detected. Back then, experts surmised that tinea
capitis was uncommon in the Philippines and was not a public
health problem, and this seems the case to this day [2]. The
common dermatophytes isolated were Microsporum canis,
Trichophyton tonsurans , T. mentagrophytes , and
M. gypseum [2]. A total of 9,180 (11.5% of new patients)
consulted for superficial mycoses in ten PDS institutions in
2015. Fungal keratitis, tinea capitis, mycetoma, and RVVC
are mycoses that affect young, productive, and otherwise
healthy patients. These affect work productivity and quality
of life. It is important to manage these diseases promptly to
avoid complications.
The incidence of subcutaneous mycoses is rare in the
Philippines, but these usually cause disfiguring lesions in
young people, limiting their mobility and affecting quality of
life [1]. By 1963, three patients with eumycetoma caused
by Penicillium funiculosum, Madurella grisea, and
Scedosporium (formerly Monosporium) apiospermum had
been seen in the Philippines [23]. Eumycetoma of 20 years
duration in a 40-year-old man was found to be caused by
Phialemonium sp., and was treated with terbinafine 250 mg
twice a day for 9 months followed by excision of redundant
skin [24]. Another case was reported in 2009 of a 33-year-old
man with draining sinuses and nodules on the left foot and
thigh, from which Madurella sp. was isolated [25]. More re-
cently, Madurella mycetomatis was cultured from the foot
lesions of 9 years duration of a 33-year-old man [26]. Most
of these patients were farmers. If eumycetoma presents with
chronic nodules and draining sinuses, chromoblastomycosis
appears as warty lesions. A few cases of chromoblastomycosis
have also been reported in the Philippines, including a 58-
year-oldmanwho presentedwith verrucous lesions of 25 years
and a 71-year-old man with warty lesions of 48 years duration
[2, 27]. Both were caused by Fonsecaea compacta.
Challenges in the management of serious fungal infections
in a resource-limited setting include timely diagnosis, proper
antifungal intervention, patient compliance with long-term
treatment, and high cost of antifungal treatment.
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